Envoy Medical, Inc.
COCH
$0.66
$0.045.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.38% | 7.11% | -25.18% | -26.49% | -28.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.38% | 7.11% | -25.18% | -26.49% | -28.62% |
| Cost of Revenue | -5.40% | -7.82% | 0.12% | -2.07% | 10.43% |
| Gross Profit | 10.95% | 14.31% | -13.12% | -12.14% | -36.73% |
| SG&A Expenses | 8.48% | 6.89% | -7.00% | -8.60% | -13.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.64% | 14.57% | -4.92% | -1.12% | -0.39% |
| Operating Income | -17.72% | -14.66% | 4.65% | 0.74% | -0.04% |
| Income Before Tax | -18.37% | -14.24% | -3.40% | -56.96% | 14.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.37% | -14.24% | -3.40% | -56.96% | 14.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.37% | -14.24% | -3.40% | -56.96% | 14.55% |
| EBIT | -17.72% | -14.66% | 4.65% | 0.74% | -0.04% |
| EBITDA | -17.31% | -14.12% | 5.15% | 1.20% | 0.27% |
| EPS Basic | 26.23% | 12.52% | -0.21% | -63.60% | 25.62% |
| Normalized Basic EPS | 15.42% | 7.80% | 8.40% | 6.88% | 54.99% |
| EPS Diluted | 26.23% | 12.52% | -0.02% | -61.69% | 26.03% |
| Normalized Diluted EPS | 15.42% | 7.80% | 8.40% | 4.43% | 54.40% |
| Average Basic Shares Outstanding | 80.57% | 23.78% | 12.57% | 21.98% | 35.09% |
| Average Diluted Shares Outstanding | 80.57% | 23.78% | 12.57% | 20.16% | 32.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.86% | 0.35% | -0.28% | -- | -- |